DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» SMARCB1
SMARCB1
SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
Integrase Interactor 1 (INI-1) Deficient Renal Cell Carcinoma
Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer
Renal Medullary Carcinomas Depend Upon SMARCB1 Loss And
Regulation of P27kip1 and P57kip2 Functions by Natural Polyphenols
Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
Global Chromatin Changes Resulting from Single-Gene Inactivation—The Role of SMARCB1 in Malignant Rhabdoid Tumor
Zytolight ® SPEC SMARCB1/22Q12 Dual Color Probe
ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
Loss of the SWI/SNF-Atpase Subunit Members SMARCF1 (ARID1A)
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor
The Chromatin Remodelling Component SMARCB1/INI1
Associations Between Human Disease Genes and Overlapping Gene Groups and Multiple Amino Acid Runs
Induction of Therapeutic Tissue Tolerance Foxp3 Expression Is
CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome William D
MIR-16 SUPPRESSES GROWTH of RHABDOID TUMOR CELLS Emily
Hereditary Cancer Panel Descriptions
Xt GENE PANEL
Top View
Durable Tumor Regression in Genetically Altered Malignant Rhabdoid Tumors by Inhibition of Methyltransferase EZH2
SMARCB1-Deficient Sinonasal Carcinoma: a Case Report and Discussion of the Clinical Implications
The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors Thomas P
Loss of ARID1A Expression and Its Relationship with PI3K-Akt Pathway
Smarcc1 Crebbp Smarcc1 Ar Smarcc1 Gata1 Smarcc1
Cryo-Electron Microscopy Structure of a Nucleosome-Bound SWI/SNF Chromatin
Clinicopathological and Molecular Characterization of SMARCA4-Deficient Thoracic Sarcomas with Comparison to Potentially Related
Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery
(12) United States Patent (10) Patent No.: US 9,429,574 B2 Nuber (45) Date of Patent: Aug
Molecular Features of the Basal-Like Breast Cancer Subtype Based on BRCA1 Mutation Status
The Achilles Heel of Malignant Rhabdoid Tumors Jing Huang and Ji Luo
SMARCB1-Mediated SWI/SNF Complex Function Is Essential for Enhancer Regulation
SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas
SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia
Rhabdoid Tumor
SMARCB1 Gene SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily B, Member 1
A Heterotrimeric SMARCB1–SMARCC2 Subcomplex Is